|
Megestrol Acetate Clinical Trials
3 actively recruiting trials across 1 location
▲ +1 trial since June 2026
Also known as: 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate, 17.alpha.-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone, 6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone, BDH 1298 +11 more
Pipeline
Phase 2: 1Phase 3: 1Phase 2/3: 1
Top Sponsors
- Sixth Affiliated Hospital, Sun Yat-sen University1
- New Mexico Cancer Research Alliance1
- Leiden University Medical Center1
Indications
- Cancer3
- Endometrial Endometrioid Adenocarcinoma1
- Neoadjuvant Chemotherapy1
- Weight Loss1
- Endometrial Hyperplasia1
Other2 trials
Iowa City, Iowa1 trial
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
University of Iowa/Holden Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.